Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa
Conditions:  Tuberculosis;  HIV Infections Interventions:  Biological: VPM1002 Vaccine;  Biological: BCG Vaccine;  Drug: Placebo Sponsors:  International Maternal Pediatric Adolescent AIDS Clinical Trials Group;  National Institute of Allergy and Infectious Diseases (NIAID);  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);  National Institute of Mental Health (NIMH) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: African Health | AIDS Vaccine | Allergy | Allergy & Immunology | Child Development | Children | Clinical Trials | HIV AIDS | Infectious Diseases | Men | Pediatrics | Research | South Africa Health | Tuberculosis | Vaccines